A Randomized Trial Assessing the Impact of a Personal Printed Feedback Portrait on Statin Prescribing in Primary Care

Dormuth, Colin R.; Carney, Greg; Taylor, Suzanne; Bassett, Ken; Maclure, Malcolm

doi:10.1002/chp.21140

Cited by 23 publications

(58 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The literature also reports 70,71 on the small number of studies applying a theoretical background and encourages its use tailored to the setting and to the aim of intervention. 70 Economic evaluation of guideline implementation interventions is rarely reported, 12,13 our hits demonstrating no exception: three studies 31,35,41 presented cost-benefit or cost-effectiveness information. This indicates that research should focus on adding this essential aspect in favour of comprehensive comparability.…”

Section: Discussionmentioning

confidence: 99%

“…distribution of materials applied on the meeting or e-learning sessions. 34,40,44,47,54,57,58 (3) Seven studies used diverse single approaches including audit, 25,31,43 motivational interview, 53 reminder 26,32 and patient-mediated intervention. 41 Multifaceted interventions mainly applied a combination of two methods, one of them a kind of training approach, extended by a second methodologically different method.…”

Section: Methods Of Interventionmentioning

confidence: 99%

See 1 more Smart Citation

Systematic Review and Meta-analysis of the Effectiveness of Implementation Strategies for Non-communicable Disease Guidelines in Primary Health Care

et al. 2018

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Methods Of Interventionmentioning

confidence: 99%

Systematic Review and Meta-analysis of the Effectiveness of Implementation Strategies for Non-communicable Disease Guidelines in Primary Health Care

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Evidence from studies of approaches to improving the adequacy and/or promoting the reduction or abandonment of low-value pharmacological prescribing shows, on the one hand, that training in isolation does not have an effect in terms of de-implementing inappropriate prescribing. On the other, multi-component interventions that combine multiple tailored interventions (audit and feedback, alert systems and clinical decision support systems) have achieved more positive results [16][17][18][19][20][21][22][23]. Nevertheless, there is no "magic bullet" to reduce clinicians' use of low-value practices [24,25].…”

Section: Introductionmentioning

confidence: 99%

Addressing low-value pharmacological prescribing in primary prevention of CVD through a structured evidence-based and theory-informed process for the design and testing of de-implementation strategies: the DE-imFAR study

et al. 2020

View full text Add to dashboard Cite

Background: De-implementation or abandonment of ineffective or low-value healthcare is becoming a priority research field globally due to the growing empirical evidence of the high prevalence of such care and its impact in terms of patient safety and social inefficiency. Little is known, however, about the factors, barriers, and facilitators involved or about interventions that are effective in promoting and accelerating the de-implementation of lowvalue healthcare. The De-imFAR study seeks to carry out a structured, evidence-based, and theory-informed process involving the main stakeholders (clinicians, managers, patients, and researchers) for the design, deployment, and assessment of de-implementation strategies for reducing low-value pharmacological prescribing. Methods: A phase I formative study using a systematic and comprehensive framework based on theory and evidence for the design of implementation strategies-specifically, the Behavior Change Wheel (BCW)-will be conducted to design and model de-implementation strategies to favor reductions in low-value pharmacological prescribing of statins in primary prevention of cardiovascular disease (CVD) by main stakeholders (clinicians, managers, patients, and researchers) in a collegiate way. Subsequently, a phase II comparative hybrid trial will be conducted to assess the feasibility and potential effectiveness of at least one active de-implementation strategy to reduce low-value pharmacological prescribing of statins in primary prevention of CVD compared to the usual procedures for dissemination of clinical practice guidelines ("what-not-to-do" recommendations). A mixed-methods evaluation will be used: quantitative for the results of the implementation at the professional level (e.g., adoption, reach and implementation or execution of the recommended clinical practice); and qualitative to determine the feasibility and perceived impact of the de-implementation strategies from the clinicians' perspective, and patients' experiences related to the clinical care received.

show abstract

“…Evidence from studies of approaches to improving adequacy and/or promoting the reduction or abandonment of low-value pharmacological prescribing shows, on the one hand, that training in isolation does not have an effect in terms of de-implementing inappropriate prescribing. On the other, multi-component interventions that combine multiple tailored interventions (audit and feedback, alert systems and clinical decision support systems) have achieved more positive results [16][17][18][19][20][21][22][23].…”

Section: Introductionmentioning

confidence: 99%

Addressing low-value pharmacological prescribing in primary prevention of CVD through a structured evidence-based and theory-informed process for the design and testing of de-implementation strategies: the DE-imFAR study

Sánchez

Pijoán

Pablo

et al. 2019

Preprint

View full text Add to dashboard Cite

Background: De-implementation or abandonment of ineffective or low-value healthcare is becoming a priority research field globally due to the growing empirical evidence of the high prevalence of such care and its impact in terms of patient safety and social inefficiency. Little is known, however, about the factors, barriers and facilitators involved or about interventions that are effective in promoting and accelerating the de-implementation of low-value healthcare. The De-imFAR study seeks to carry out a structured, evidence-based and theory-informed process involving the main stakeholders (clinicians, managers, patients and researchers) for the design, deployment and assessment of de-implementation strategies for reducing low-value pharmacological prescribing.Methods: A Phase I formative study using a systematic and comprehensive framework based on theory and evidence for the design of implementation strategies – specifically, the Behavior Change Wheel (BCW) - will be conducted to design and model de-implementation strategies to favour reductions in low-value pharmacological prescribing of statins in primary prevention of cardiovascular disease (CVD) by main stakeholders (clinicians, managers, patients and researchers) in a collegiate way. Subsequently, a Phase II comparative hybrid trial will be conducted to assess the feasibility and potential effectiveness of at least one active de-implementation strategy to reduce low-value pharmacological prescribing of statins in primary prevention of CVD compared to the usual procedures for dissemination of clinical practice guidelines ("what-not-to-do" recommendations). A mixed methods evaluation will be used: quantitative for the results of the implementation at the professional level (e.g., adoption, reach and implementation or execution of the recommended clinical practice); and qualitative to determine the feasibility and perceived impact of the de-implementation strategies from the clinicians’ perspective, and patients’ experiences related to the clinical care received.Discussion: The DE-imFAR study aims to generate valid scientific knowledge about the design and development of de-implementation strategies using theory- and evidence-based methodologies suggested by implementation science. It will explore the effectiveness of these strategies and their acceptability among clinicians, policy makers and patients. Its ultimate goal is to maximize the quality and efficiency of our health system by abandoning low-value pharmacological prescribing.

show abstract

A Randomized Trial Assessing the Impact of a Personal Printed Feedback Portrait on Statin Prescribing in Primary Care

Abstract: The individualized prescribing portrait had a significant beneficial effect on new statin prescribing for primary prevention but not secondary prevention. Provincial drug plan costs appear to have been reduced to a level that exceeded the cost of the program.

Cited by 23 publications

References 23 publications

Systematic Review and Meta-analysis of the Effectiveness of Implementation Strategies for Non-communicable Disease Guidelines in Primary Health Care

Systematic Review and Meta-analysis of the Effectiveness of Implementation Strategies for Non-communicable Disease Guidelines in Primary Health Care

Addressing low-value pharmacological prescribing in primary prevention of CVD through a structured evidence-based and theory-informed process for the design and testing of de-implementation strategies: the DE-imFAR study

Addressing low-value pharmacological prescribing in primary prevention of CVD through a structured evidence-based and theory-informed process for the design and testing of de-implementation strategies: the DE-imFAR study

Contact Info

Product

Resources

About